Opioid Overdose Reversal With Nalmefene Nasal Spray: A Case Report

Michel Sucher1, Lisa Emmans2

  • 1Substance Use and Addiction, Honor Health Addiction Medicine, Phoenix, USA.

Cureus
|June 16, 2025
PubMed

Insights

Intranasal nalmefene effectively reversed an opioid overdose, showing rapid improvement in oxygen saturation and mental status. The patient experienced no precipitated withdrawal, supporting its use in emergency overdose response.

Area of Science:

  • Emergency Medicine
  • Pharmacology

Background:

  • Recent FDA approval of intranasal (IN) nalmefene for opioid overdose reversal.
  • Limited published evidence exists on IN nalmefene's clinical utilization and potential for precipitated withdrawal.

Observation:

  • Physician investigators reviewed bodycam footage, dispatch reports, and interview data of a patient receiving IN nalmefene post-opioid overdose.
  • Clinical signs and symptoms were assessed before, during, and after IN nalmefene administration.

Findings:

  • Rapid improvement in oxygen saturation (up to 98%) within 2.5 minutes post-administration.
  • Marked improvement in patient's mental status observed.
  • No evidence of precipitated withdrawal was noted in the patient.

Implications:

  • IN nalmefene demonstrates potential for rapid and effective opioid overdose reversal.
  • Further studies are crucial to establish IN nalmefene's role for first responders and its impact on patient outcomes.
  • This case study supports the safety and efficacy of IN nalmefene in clinical settings.

Related Concept Videos

Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
7.2K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.3K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.7K
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K